share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  05/28 11:31
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Charles F. Wagner Jr. is set to sell 3,250 shares of common stock on 05/28/2024, as announced by the company. The shares, valued at approximately $1,478,067.50, were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,199 shares obtained on 02/10/2023 and an additional 2,051 shares on 02/13/2023. The planned sale follows the adoption of a trading plan on 02/26/2024. There have been no other reported sales of securities by Wagner in the past three months.
Vertex Pharmaceuticals Inc. officer Charles F. Wagner Jr. is set to sell 3,250 shares of common stock on 05/28/2024, as announced by the company. The shares, valued at approximately $1,478,067.50, were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,199 shares obtained on 02/10/2023 and an additional 2,051 shares on 02/13/2023. The planned sale follows the adoption of a trading plan on 02/26/2024. There have been no other reported sales of securities by Wagner in the past three months.
据Vertex Pharmicals Inc.宣布,该公司高管小查尔斯·瓦格纳定于2024年5月28日出售3,250股普通股。这些股票价值约1,478,067.50美元,是通过限制性股票归属作为补偿的一部分收购的,其中1,199股于2023年10月2日获得,2023年2月13日又获得了2,051股。计划出售是在2024年2月26日通过交易计划之后进行的。在过去的三个月中,瓦格纳没有其他证券销售的报道。
据Vertex Pharmicals Inc.宣布,该公司高管小查尔斯·瓦格纳定于2024年5月28日出售3,250股普通股。这些股票价值约1,478,067.50美元,是通过限制性股票归属作为补偿的一部分收购的,其中1,199股于2023年10月2日获得,2023年2月13日又获得了2,051股。计划出售是在2024年2月26日通过交易计划之后进行的。在过去的三个月中,瓦格纳没有其他证券销售的报道。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息